Anti-cancer activity of 1,3,4-oxadiazole and its derivative

Anti-cancer activity of 1,3,4-oxadiazole and its derivative

Registration ID: IJNRD_206247

Published ID: IJNRD2310013

DOI: https://doi.org/10.5281/zenodo.12743599

KOUSIK MAPARU , RITAM MUKHERJEE , DHRITA CHATTERJEE

Oxadiazole ring , anticancer activity , HDAC , Proliferation , anti-tumor

Nowadays cancer is a leading cause of death, the most common cancers worldwide are breast, colorectal, and lung cancer. Data from the International agency for Research on Cancer (IARC) says 19.3 million new cases of cancer and 10 million deaths. Oxidaizole derivatives are compounds having 5-membered rings containing one oxygen and two nitrogen atoms such as oxacillin, sulfamethoxazole, acivicin, and cycloserine have containing oxadiazole ring . 1,3,4 oxadiazole derivatives have the demand for researchers because of their various activities such as antibacterial, anti-tumor, antiviral, and antioxidant. Nowadays there are potent medicines in the market having anticancer activity, used worldwide. Some examples of anticancer agents available in the market are bleomycin and tiazofurin. There are some various mechanisms of action of 1,3,4 oxadiazole derivatives for anticancer activity, by acting on some enzymes likes thymidylate-syn-thase, HDAC(histone deacetylase ), topoisomerase II, telomerase, thymidine phosphorylase to stop proliferation and also acting some pathways likes inhibiting telomerase activity, focal adhesion kinase(FAK) inhibitors, targeting thymidylate synthase, an inhibitor of the B-cell lymphoma 2, inhibitor of NF-kB signaling pathway and targeting tubulin polymerization. So,1,3,4-oxadiazole used as a promising anticancer drug in future.

Published Paper   E-Certificate

"Anti-cancer activity of 1,3,4-oxadiazole and its derivative", IJNRD - INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (www.IJNRD.org), ISSN:2456-4184, Vol.8, Issue 10, page no.a84-a95, October-2023, Available :https://ijnrd.org/papers/IJNRD2310013.pdf

Volume 8 Issue 10, October-2023

Pages : a84-a95

Paper Reg. ID: IJNRD_206247

Published Paper Id: IJNRD2310013

Downloads: 000121187

Research Area: Pharmacy

Country: East Medinipur , West Bengal , India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2310013.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2310013

DOI: https://doi.org/10.5281/zenodo.12743599

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 8 | August 2025

IJNRD is Scholarly open access journals, Peer-reviewed, and Refereed Journals, High Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) with Open-Access Publications.

INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world. IJNRD will provide an opportunity for practitioners and educators of engineering field to exchange research evidence, models of best practice and innovative ideas.

Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: August 2025

Current Issue: Volume 10 | Issue 8

Last Date for Paper Submission: Till 31-Aug-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: International Peer-reviewed, Refereed, and Open Access Journal.

Subject Category: Research Area